AstraZeneca pays SEC US$5.5 million after 10-year FCPA investigation

UK-based pharmaceutical company AstraZeneca will pay US$5.5 million to resolve charges it violated the Foreign Corrupt Practices Act, while the Justice Department has closed its investigation into the matter.

Get unlimited access to all Global Investigations Review content